| Outcome Measures: |
Primary: Change From Baseline in Hemoglobin A1C (HbA1C) at Week 30, HbA1C is blood marker used to report average blood glucose levels over a prolonged periods of time and is reported as a percentage (%). Change in A1C following 30 weeks of therapy (i.e., A1C at Week 30 minus A1C at baseline)., Baseline and Week 30|Number of Participants Who Experienced at Least One Adverse Event (AE), An adverse event (AE) is any unfavorable and unintended change in the structure, function or chemistry of the body temporally associated with study drug administration whether or not considered related to the use of the product., Up to 32 weeks|Number of Participants Who Discontinued Study Drug Due to an Adverse Event, An AE is any unfavorable and unintended change in the structure, function or chemistry of the body temporally associated with study drug administration whether or not considered related to the use of the product., Up to 30 weeks | Secondary: Change From Baseline in Fasting Plasma Glucose (FPG) at Week 30, Blood glucose was measured on a fasting basis (collected after an 8- to 10-hour fast). FPG is expressed as mg/dL. Blood was drawn at predose on Day 1 and after 30 weeks of treatment to determine change in plasma glucose levels (i.e., FPG at Week 30 minus FPG at baseline)., Baseline and Week 30|Percentage of Participants With One or More Episodes of Hypoglycemia, Symptomatic episodes assessed as likely to be due to hypoglycemia were reported by investigators as adverse experiences of hypoglycemia. Adverse experiences of hypoglycemia were based on all reports of hypoglycemia; a concurrent glucose measurement was not required., Up to Week 30|Change From Baseline in Body Weight at Week 30, Change in body weight following 30 weeks of therapy (i.e., body weight at Week 30 minus body weight at baseline), Baseline and Week 30|Percentage of Participants With HbA1C < 7.0% at Week 30, HbA1C is blood marker used to report average blood glucose levels over a prolonged periods of time and is reported as a percentage (%)., Week 30
|
